Literature DB >> 22164521

FDA notifications. Complera approved.

.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 22164521

Source DB:  PubMed          Journal:  AIDS Alert        ISSN: 0887-0292


× No keyword cloud information.
  3 in total

1.  Rilpivirine resistance-associated mutations among antiretroviral-naive patients infected with HIV-1 in Asia.

Authors:  Somnuek Sungkanuparph; Awachana Jiamsakul; Sasisopin Kiertiburanakul; Sunee Sirivichayakul; Jutarat Praparattanapan; Rami Kantor
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731

2.  The demise of multidrug-resistant HIV-1: the national time trend in Portugal.

Authors:  Jurgen Vercauteren; Kristof Theys; Ana Patricia Carvalho; Emília Valadas; Luis Miguel Duque; Eugénio Teófilo; Telo Faria; Domitília Faria; José Vera; Maria João Aguas; Susana Peres; Kamal Mansinho; Anne-Mieke Vandamme; Ricardo Jorge Camacho
Journal:  J Antimicrob Chemother       Date:  2012-12-09       Impact factor: 5.790

3.  New option for management of HIV-1 infection in treatment-naive patients: once-daily, fixed-dose combination of rilpivirine-emtricitabine-tenofovir.

Authors:  Nimish Patel; Christopher D Miller
Journal:  HIV AIDS (Auckl)       Date:  2012-04-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.